General Information
Empagliflozin belongs to a class of substances called hypoglycemic agents, which lower glucose levels in the blood. It is indicated as an adjunct to diet and exercise to improve glycemic (blood sugar) control in adults with type 2 diabetes mellitus.
About the API
Systematic name
D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S)
Trade name(s)
Jardiance
Technology
Synthetic
Molecular Formula
C23H27ClO7
Molecular Weight
450.90928
Physical properties
non-hygroscopic powder
Therapeutic category
Diabetes
Available formulations
Oral Solid
Regulations
US DMF
US DMF